Daiwa Securities Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
31,896
+50
| +0.2% | +$1.8K | ﹤0.01% | 724 |
|
|
2025
Q1 | $991K | Buy |
31,846
+1,350
| +4% | +$42K | ﹤0.01% | 728 |
|
|
2024
Q4 | $778K | Sell |
30,496
-198
| -0.6% | -$5.05K | ﹤0.01% | 764 |
|
|
2024
Q3 | $868K | Buy |
30,694
+3,000
| +11% | +$84.8K | ﹤0.01% | 751 |
|
|
2024
Q2 | $730K | Buy |
27,694
+1,180
| +4% | +$31.1K | ﹤0.01% | 762 |
|
|
2024
Q1 | $805K | Sell |
26,514
-10,129
| -28% | -$308K | ﹤0.01% | 758 |
|
|
2023
Q4 | $1.03M | Buy |
36,643
+4,007
| +12% | +$113K | 0.01% | 691 |
|
|
2023
Q3 | $886K | Sell |
32,636
-350
| -1% | -$9.5K | 0.01% | 703 |
|
|
2023
Q2 | $1.01M | Buy |
32,986
+1,588
| +5% | +$48.8K | 0.01% | 660 |
|
|
2023
Q1 | $1.13M | Buy |
31,398
+371
| +1% | +$13.4K | 0.01% | 630 |
|
|
2022
Q4 | $1.23M | Buy |
31,027
+1,859
| +6% | +$73.5K | 0.01% | 596 |
|
|
2022
Q3 | $1.17M | Buy |
29,168
+162
| +0.6% | +$6.51K | 0.01% | 592 |
|
|
2022
Q2 | $1.22M | Buy |
29,006
+1,211
| +4% | +$50.9K | 0.01% | 590 |
|
|
2022
Q1 | $1.08M | Buy |
27,795
+9,566
| +52% | +$373K | 0.01% | 680 |
|
|
2021
Q4 | $726K | Buy |
18,229
+399
| +2% | +$15.9K | ﹤0.01% | 784 |
|
|
2021
Q3 | $644K | Buy |
17,830
+1,250
| +8% | +$45.1K | ﹤0.01% | 787 |
|
|
2021
Q2 | $680K | Buy |
16,580
+1,019
| +7% | +$41.8K | ﹤0.01% | 751 |
|
|
2021
Q1 | $679K | Sell |
15,561
-1,539
| -9% | -$67.2K | 0.01% | 728 |
|
|
2020
Q4 | $856K | Buy |
17,100
+2,866
| +20% | +$143K | 0.01% | 612 |
|
|
2020
Q3 | $599K | Buy |
+14,234
| New | +$599K | 0.01% | 642 |
|